FLUOGUIDE A/S DK -1

Research FLUOGUIDE A/S DK -1 (96X) on Bullrun: market cap EUR 43.98M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker96X
ExchangeF
CountryDenmark
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 43.98M
Financial periodQ1 2026
RevenueDKK 0
Net income-DKK 11.79M
Free cash flow-DKK 15.20M

Valuation Snapshot

latest market cap is EUR 43.98M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	DKK 0	-DKK 39.46M	-DKK 36.96M	n/a	-2.79	DKK 48.79M	DKK 28.29M	DKK 54.53M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-27	EUR 43.98M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About FLUOGUIDE A/S DK -1

FluoGuide A/S, a clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark. The company offers FG001, an urokinase-type plasminogen activator receptor target imaging agent, which is in Phase II clinical trial for the treatment of high-grade glioma and lung, head, and neck cancer; and functions as a photosensitizer, which is in pre-clinical stage for the treatment of brain cancer through photothermal and photodynamic therapies.

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Strategic Partners A/S (1TB0) 2cureX AB (2CUREX) CESSATECH A/S DK -20 (8GN) ALK-Abelló A/S (ALK-B) Ascendis Pharma A/S (ASND) Bavarian Nordic A/S (BV3A) Evaxion Biotech A/S (EVAX) GENMAB (GE9) Genmab (GMAB) Gubra A/S (GUBRA) Initiator Pharma A/S (INIT) Pharma Equity Group (PEG.CO)

Frequently asked questions

What is FLUOGUIDE A/S DK -1's market cap?

FLUOGUIDE A/S DK -1's market capitalization is EUR 43.98M.